Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial

BACKGROUND: Brain injuries resulting from motor vehicle accidents and falls, as well as hypoxic insults and other conditions, are one of the leading causes of disability and death in the world. Current treatments are limited but include continuous rehabilitation, especially for chronic brain injury....

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Shinichi, Yamaki, Tomohiro, Sasaki, Masanori, Ukai, Ryo, Takemura, Mitsuhiro, Yokoyama, Takahiro, Kataoka-Sasaki, Yuko, Onodera, Rie, Ito, Yoichi M, Kobayashi, Shigeki, Kocsis, Jeffery D, Iwadate, Yasuo, Honmou, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301565/
https://www.ncbi.nlm.nih.gov/pubmed/35793128
http://dx.doi.org/10.2196/37898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301565/
https://www.ncbi.nlm.nih.gov/pubmed/35793128
http://dx.doi.org/10.2196/37898

Ejemplares similares